{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibo75mthvtpbup5asmogpqp6rrewe7pbzcquhnj6o6uhnw2p3maea",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mgnoli7wx5k2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiabm47l5kzqghmulwfbupuckvipkdt6uv633xabxfthn4ahjggjfm"
    },
    "mimeType": "image/jpeg",
    "size": 299151
  },
  "path": "/news/2026-03-cancer-drug-early-alzheimer-brain.html",
  "publishedAt": "2026-03-09T14:40:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the very early stages of Alzheimer's disease. Published in Translational Psychiatry, the study also demonstrated that a cancer medication has the potential to reduce this hyperconnectivity.",
  "title": "Cancer drug reduces early Alzheimer's-like brain hyperconnectivity in lab tests"
}